Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection
- PMID: 31513595
- PMCID: PMC6742465
- DOI: 10.1371/journal.pone.0216847
Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection
Abstract
Background: Although gross vascular invasion (VI) has prognostic significance in patients with hepatocellular carcinoma (HCC) who have undergone hepatic resection, few studies have investigated the relationship between gross VI and aberrant expression of microribonucleic acids (miRNAs and miRs). Thus, the objective of this study was to identify miRNAs selectively expressed in HCC with gross VI and investigate their prognostic significance.
Materials and methods: Eligible two datasets (accession number: GSE20594 and GSE67140) were collected from the National Center for Biotechnology Information's (NCBI) Gene Expression Omnibus (GEO) database to compare miRNAs expression between HCC with and without gross VI. Differentially expressed miRNAs were externally validated using expression data from The Cancer Genome Atlas (TCGA) database. Prognostic significance and predicted functions of selected miRNAs for HCC were also investigated.
Results: Thirty-five miRNAs were differentially expressed between HCC with and without gross VI in both datasets. Among them, three miRNAs were validated using TCGA database. miR-99a, miR-100, and miR-148a were downregulated to a greater extent in patients with HCC and gross VI than in those with HCC but no gross VI. Receiver operating characteristic (ROC) curve analysis showed discriminatory power of these miRNAs in predicting gross VI. Multivariate survival analysis revealed that types of surgery, advanced tumor node metastasis (TNM) stage, and low expression of miR-100-5p were independently associated with tumor recurrence. It also revealed that types of surgery, advanced TNM stage, low expression of miR-100-5p and miR-148a-3p were independent risk factors for overall survival (OS) after hepatic resection for HCC. A text mining analysis revealed that these miRNAs were linked to multifaceted hallmarks of cancer, including "invasion and metastasis."
Conclusions: Low expressions of miR-100-5p and miR-148a-3p were associated with gross VI and poor survival of patients after hepatic resection for HCC.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion.BMC Med Genomics. 2022 Feb 24;15(1):34. doi: 10.1186/s12920-022-01162-7. BMC Med Genomics. 2022. PMID: 35197055 Free PMC article.
-
Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.J Transl Med. 2018 Sep 29;16(1):266. doi: 10.1186/s12967-018-1639-8. J Transl Med. 2018. PMID: 30268144 Free PMC article.
-
Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.Oncotarget. 2015 Sep 22;6(28):25093-108. doi: 10.18632/oncotarget.4437. Oncotarget. 2015. PMID: 26231037 Free PMC article.
-
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.Sci Rep. 2018 Jun 15;8(1):9227. doi: 10.1038/s41598-018-27521-y. Sci Rep. 2018. PMID: 29907753 Free PMC article. Review.
-
The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.Medicine (Baltimore). 2019 Mar;98(13):e14810. doi: 10.1097/MD.0000000000014810. Medicine (Baltimore). 2019. PMID: 30921182 Free PMC article.
Cited by
-
Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review).Am J Cancer Res. 2024 Sep 15;14(9):4113-4171. doi: 10.62347/UJVP4361. eCollection 2024. Am J Cancer Res. 2024. PMID: 39417171 Free PMC article. Review.
-
A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion.BMC Med Genomics. 2022 Feb 24;15(1):34. doi: 10.1186/s12920-022-01162-7. BMC Med Genomics. 2022. PMID: 35197055 Free PMC article.
-
Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma.Mol Biol Rep. 2023 Sep;50(9):7681-7691. doi: 10.1007/s11033-023-08586-z. Epub 2023 Jul 7. Mol Biol Rep. 2023. PMID: 37418086 Review.
-
Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization.World J Clin Cases. 2020 Aug 26;8(16):3493-3502. doi: 10.12998/wjcc.v8.i16.3493. World J Clin Cases. 2020. PMID: 32913856 Free PMC article.
-
Bio-diagnostic performances of microRNAs set related to DNA damage response pathway among hepatitis C virus-associated hepatocellular carcinoma patients.J Genet Eng Biotechnol. 2023 Aug 17;21(1):85. doi: 10.1186/s43141-023-00537-2. J Genet Eng Biotechnol. 2023. PMID: 37587273 Free PMC article.
References
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015;65:87–108. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical